Supernus Pharmaceuticals | SUPN - Trade Debtors


Supernus Pharmaceuticals reported $187.8M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Eisai JPY 249.06B 25B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Pacira USD 124.07M 8.8M Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025